PCSK9 抑制剂（CLISIRAN）
PCSK9 inhibitors have revolutionised the treatment of hyperlipidaemia and atherosclerotic cardiovascular disease. PCSK9 (Proprotein convertase subtilisin/kexin type 9 ) is a protein…
Day: 25 February 2025
PCSK9 inhibitors have revolutionised the treatment of hyperlipidaemia and atherosclerotic cardiovascular disease. PCSK9 (Proprotein convertase subtilisin/kexin type 9 ) is a protein…
We use cookies to personalise content, analyse traffic, and improve your experience. By continuing to use our site, you agree to our use of cookies. Learn more in our Cookie Policy and Privacy Policy.
